+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bone Growth Stimulator Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • PDF Icon

    Report

  • 147 Pages
  • September 2023
  • Region: Global
  • IMARC Group
  • ID: 5633266

Quick Summary:

In a rapidly evolving healthcare landscape, understanding the dynamics of the global bone growth stimulator market is a key strategic move for any business leader seeking growth. These advanced medical devices, designed to enhance bone healing after spinal fusion surgery or fracture, leverage ultrasonic or pulsed electromagnetic waves to promote tissue repair and incremental bone density. Not only do they aid in treating nonunion fractures, but they bring significant advantages to the table - from painless healing and lower complication rates to bolstering patient compliance. Today, these innovative solutions are being utilized worldwide in various settings such as hospitals, clinics, and home care centers.

Among the current market trends, a noticeable surge in demand for minimally invasive procedures has been observed, driven by reduced operative complications, less lengthy hospital stays, quicker recovery times and fewer infection risks, to name a few. Coupled with a globally aging population, this trend is substantially propelling the bone growth stimulator market forward. Additionally, rising incidences of sports-related orthopedic injuries, governmental investment in medical devices, and burgeoning healthcare sectors globally, all contribute to the market's potential. Increased awareness of bone growth stimulators among healthcare professionals and patients, along with a higher prevalence of medical conditions likely to benefit from such treatments, keep fueling this market’s strength.

The global bone growth stimulator market size reached US$ 2.0 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 2.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.05% during 2023-2028.

A bone growth stimulator is a medical device used to boost the healing process of bones after a spinal fusion surgery or fracture. It relies on ultrasonic or pulsed electromagnetic waves to assist the body in tissue repairing and cell creation while increasing bone density. It helps treat nonunion fractures that occur due to the lack of stability, blood flow, and infections, particularly after surgery. In addition, it offers several advantages, including a painless healing process, low complication rates compared to other invasive methods, and increasing patient compliance. As a result, it finds extensive applications in hospitals, clinics, and home care centers across the globe.

Bone Growth Stimulator Market Trends:

At present, there is a rise in the demand for minimally invasive (MI) procedures due to fewer operative complications, shorter hospitalization, less pain, reduced postoperative care, quicker recovery, smaller and more cosmetic incisions, and lower risk of infection. This, along with the growing geriatric population around the world, represents one of the key factors driving the market. Moreover, the increasing sports-related orthopedic injuries among individuals due to poor training practices, improper equipment, insufficient warm-up and stretching, and lack of conditioning are propelling the growth of the market. In addition, governments of several countries are extensively investing in medical equipment and devices. This, coupled with the burgeoning healthcare industry across the globe, is offering lucrative growth opportunities to industry players. Besides this, the growing awareness among physicians, surgeons, and patients about the benefits of bone growth stimulators for spinal fusion and bone healing is positively influencing the market. Additionally, the rising prevalence of arthritis, diabetes, and other medical conditions, such as obesity, vascular disease, and renal disorders, is strengthening the market growth.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global bone growth stimulator market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on product, application and end user.

Breakup by Product:

  • Bone Growth Stimulation Devices
  • Bone Morphogenetic Proteins
  • Platelet-Rich Plasma

Breakup by Application:

  • Spinal Fusion Surgeries
  • Delayed Union and Nonunion Bone Fractures
  • Oral and Maxillofacial Surgeries
  • Others

Breakup by End User:

  • Hospitals and Clinics
  • Home Care
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc., DJO Global Inc., Elizur Corporation, IGEA S.p.A., Isto Biologics, Ito Co. Ltd., Medical Device Business Services Inc. (Johnson & Johnson), Medtronic Plc, Orthofix Medical Inc., Ossatec Benelux B.V., Stryker Corporation, Terumo Bct Inc. (Terumo Corporation) and Zimmer Biomet

Key Questions Answered in This Report:

  • How has the global bone growth stimulator market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global bone growth stimulator market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global bone growth stimulator market and who are the key players?
  • What is the degree of competition in the industry?
Frequently Asked Questions about the Global Bone Growth Stimulator Market

What is the estimated value of the Global Bone Growth Stimulator Market?

The Global Bone Growth Stimulator Market was estimated to be valued at $2 Billion in 2022.

What is the growth rate of the Global Bone Growth Stimulator Market?

The growth rate of the Global Bone Growth Stimulator Market is 5.1%, with an estimated value of $2.7 Billion by 2028.

What is the forecasted size of the Global Bone Growth Stimulator Market?

The Global Bone Growth Stimulator Market is estimated to be worth $2.7 Billion by 2028.

Who are the key companies in the Global Bone Growth Stimulator Market?

Key companies in the Global Bone Growth Stimulator Market include Arthrex Inc., DJO Global Inc., Elizur Corporation, IGEA S.p.A., Isto Biologics, Ito Co. Ltd., Medical Device Business Services Inc. (Johnson & Johnson), Medtronic Plc, Orthofix Medical Inc. and Ossatec Benelux B.V..

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Bone Growth Stimulator Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Bone Growth Stimulation Devices
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Bone Morphogenetic Proteins
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Platelet-Rich Plasma
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Application
7.1 Spinal Fusion Surgeries
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Delayed Union and Nonunion Bone Fractures
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Oral and Maxillofacial Surgeries
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Home Care
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Arthrex Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 SWOT Analysis
14.3.2 DJO Global Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Elizur Corporation
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 IGEA S.p.A.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Isto Biologics
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Ito Co. Ltd.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Medical Device Business Services Inc. (Johnson & Johnson)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Medtronic Plc
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Orthofix Medical Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Ossatec Benelux B.V.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Stryker Corporation
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.12 Terumo Bct Inc. (Terumo Corporation)
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 SWOT Analysis
14.3.13 Zimmer Biomet
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis

Companies Mentioned

  • Arthrex Inc.
  • DJO Global Inc.
  • Elizur Corporation
  • IGEA S.p.A.
  • Isto Biologics
  • Ito Co. Ltd.
  • Medical Device Business Services Inc. (Johnson & Johnson)
  • Medtronic Plc
  • Orthofix Medical Inc.
  • Ossatec Benelux B.V.
  • Stryker Corporation
  • Terumo Bct Inc. (Terumo Corporation)
  • Zimmer Biomet

Methodology

Loading
LOADING...